Ashland launches intestinal permeation enhancer for oral drugs

Ashland has commercially launched permexa sodium caprate, an intestinal permeation enhancer for oral peptide and biologic drug products. The excipient supports oral alternatives to injectable therapies for conditions such as diabetes and weight loss.